TLDR: Mark Cuban Cost Plus Drugs Company has announced a strategic partnership with Medchat.ai to deploy AI customer care agents. This collaboration aims to significantly enhance customer support and accelerate access to affordable medications by automating responses to common inquiries, pricing questions, order status, and real-time delivery tracking. The integration of AI is expected to allow Cost Plus Drugs to scale its operations and serve more patients without increasing overhead costs, reinforcing its mission of transparent and affordable drug pricing.
CHARLOTTE, N.C. and DALLAS – October 28, 2025 – Mark Cuban Cost Plus Drugs Company (MCCPDC), a public-benefit corporation committed to transforming the pharmaceutical industry, has officially partnered with Medchat.ai, a leader in AI-powered healthcare automation. This strategic alliance is set to revolutionize customer support and streamline consumers’ access to safe, affordable medicines through the deployment of advanced AI customer care agents.
The newly introduced AI agents are designed to provide instant, personalized assistance across a range of customer needs, including inquiries about medication pricing, current order status, and real-time delivery tracking. This automation is a critical step for Cost Plus Drugs, enabling the company to serve an exponentially larger patient base without incurring additional overhead expenses. This directly supports their core mission of offering medications at transparent, cost-plus pricing.
Matt Yagey, CEO of Medchat.ai, expressed enthusiasm for the partnership, stating, “We’re excited to partner with Mark Cuban Cost Plus Drugs, a company that shares our commitment to transparency, affordability, and patient-centric care. Together, we’re making it easier for patients to get the answers and medications they need, faster than ever before.” The collaboration underscores a shared vision to improve patient experience and operational efficiency within the healthcare sector.
Dr. Alex Oshmyansky, co-founder and CEO of Mark Cuban Cost Plus Drugs, echoed this sentiment: “We are thrilled to collaborate with Medchat.ai in our mission to make prescription drugs more accessible and affordable for consumers. At Cost Plus Drugs, our commitment to transparent drug pricing has always been at the core of everything we do, and with partners like Medchat.ai, we are now able to bring a level of support to consumers that matches our mission.” This initiative is poised to help millions of Americans who have previously been unable to afford essential medications due to high prices.
Also Read:
- Authenticx Unveils AI Agent Assist on Salesforce AppExchange to Elevate Healthcare Customer and Agent Interactions
- Clinical AI Poised for Explosive Growth to $188 Billion by 2030, Navigating Key Hurdles
The partnership signifies a broader trend in healthcare technology, where artificial intelligence is increasingly leveraged to create superior patient experiences and foster more efficient operating models. Medchat.ai’s mission is to transform healthcare by enabling organizations to deliver instant, personalized support throughout the entire patient journey, from initial questions to treatment and follow-up care, while achieving measurable business impact at scale.
